1-5 of 5
Hussein A. Abbas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Measurable Residual Disease Clearance Kinetics in Patients with AML Undergoing Intensive Chemotherapy

Wei Ying Jen, Koji Sasaki, Farhad Ravandi, Tapan M. Kadia, Sa A. Wang, Wei Wang, Sanam Loghavi, Naval G. Daver, Courtney D. DiNardo, Ghayas C. Issa, Hussein A. Abbas, Cedric Nasnas, Alex Bataller, Samuel Urrutia, Omer S. Karrar, Sherry A Pierce, Hagop M Kantarjian, Nicholas J. Short
Journal: Blood Advances
Blood Adv bloodadvances.2024013826.
https://doi.org/10.1182/bloodadvances.2024013826
Published: 2024
Includes: Supplemental data
Journal Articles

TET2 truncating mutations predict a worse outcome in blastic plasmacytoid dendritic cell neoplasm

Hannah Beird, C. Cameron Yin, Joseph D. Khoury, Sherry Pierce, Hussein A. Abbas, Li Zhao, Anna Skwarska, Muzaffar Qazilbash, Marina Konopleva, P. Andrew Futreal, Naveen Pemmaraju
Journal: Blood Advances
Blood Adv (2023) 7 (10): 2000–2003.
https://doi.org/10.1182/bloodadvances.2022007879
Published: 2023
Includes: Supplemental data
Journal Articles

Validation of the ALFA-1200 model in older patients with AML treated with intensive chemotherapy

Clinical Trials & Observations
Hussein A. Abbas, Hanxiao Sun, Sherry Pierce, Rashmi Kanagal-Shamanna, Ziyi Li, Musa Yilmaz, Gautam Borthakur, Adam J. DiPippo, Elias Jabbour, Marina Konopleva, Nicholas J. Short, Courtney DiNardo, Naval Daver, Farhad Ravandi, Tapan M. Kadia
Journal: Blood Advances
Blood Adv (2023) 7 (5): 828–831.
https://doi.org/10.1182/bloodadvances.2022007172
Published: 2023
Includes: Supplemental data
Journal Articles

Validation of ALFA 1200 score in patients with AML >60 years treated with double nucleoside–based low-intensity therapy

Sangeetha Venugopal, Gautam Borthakur, Naval Daver, Courtney D. DiNardo, Naveen Pemmaraju, Nicholas J. Short, Hussein A. Abbas, Guillermo Garcia-Manero, Marina Konopleva, Farhad Ravandi, Tapan M. Kadia
Journal: Blood Advances
Blood Adv (2022) 6 (19): 5546–5549.
https://doi.org/10.1182/bloodadvances.2021006689
Published: 2022
Journal Articles

Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti–PD-1–based therapy

Hussein A. Abbas, Zoe Alaniz, Sean Mackay, Matthew Cyr, Jing Zhou, Ghayas C. Issa, Mansour Alfayez, Jairo Matthews, Steven M. Kornblau, Elias Jabbour, Guillermo Garcia-Manero, Marina Konopleva, Michael Andreeff, Naval Daver
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4569–4574.
https://doi.org/10.1182/bloodadvances.2021004583
Published: 2021
Includes: Supplemental data